Company intelligence / Profile preview

Prenato

Ownership: Private
Development stage: Other

Overview

Prenato is an active company specializing in non-invasive prenatal testing. It offers blood-based diagnostic services to screen for fetal chromosomal abnormalities and other genetic conditions during pregnancy. The company operates in the healthcare/femtech sector with a focus on improving access to advanced prenatal care through innovative technology. No clinical trial results are reported as it is a commercial diagnostic service.

Therapeutic areas: Women's Health
Modalities: Non-invasive prenatal testing (NIPT)Diagnostic test (blood-based screening)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Prenato.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prenato.

Explore the full profile